These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 32324131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Platelet Dysfunction and Intracerebral Hemorrhage in a Patient Treated with Empiric Piperacillin-Tazobactam in the Neurocritical Care Unit.
    Bower M, Borders C, Schnure A, Groysman L, Tran MH.
    World Neurosurg; 2018 Jun; 114():204-210. PubMed ID: 29555607
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Risk factors of nosocomial infections caused by piperacillin-tazobactam resistant Pseudomonas aeruginosa].
    Djordjević Z, Gajović O, Mijailović Z, Ilić A, Stolić R.
    Srp Arh Celok Lek; 2013 Jun; 141(9-10):640-7. PubMed ID: 24364227
    [Abstract] [Full Text] [Related]

  • 6. Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Beaulieu C, Kurczewski L, Yajnik V.
    J Thromb Thrombolysis; 2019 Jul; 48(1):167-170. PubMed ID: 30968302
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs.
    Duszynska W, Taccone FS, Switala M, Hurkacz M, Kowalska-Krochmal B, Kübler A.
    Int J Antimicrob Agents; 2012 Feb; 39(2):153-8. PubMed ID: 22154855
    [Abstract] [Full Text] [Related]

  • 10. Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.
    Speich R, Imhof E, Vogt M, Grossenbacher M, Zimmerli W.
    Eur J Clin Microbiol Infect Dis; 1998 May; 17(5):313-7. PubMed ID: 9721959
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial.
    Alvarez-Lerma F, Insausti-Ordeñana J, Jordá-Marcos R, Maraví-Poma E, Torres-Martí A, Nava J, Martínez-Pellús A, Palomar M, Barcenilla F, Spanish Collaborative Group for the Study of Severe Infections.
    Intensive Care Med; 2001 Mar; 27(3):493-502. PubMed ID: 11355117
    [Abstract] [Full Text] [Related]

  • 14. Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Jaccard C, Troillet N, Harbarth S, Zanetti G, Aymon D, Schneider R, Chiolero R, Ricou B, Romand J, Huber O, Ambrosetti P, Praz G, Lew D, Bille J, Glauser MP, Cometta A.
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2966-72. PubMed ID: 9797234
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY, Huang JC, Shen MC, Chuang SH, Lee MH, Chen HC.
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nephrotoxicity during Vancomycin Therapy in Combination with Piperacillin-Tazobactam or Cefepime.
    Rutter WC, Cox JN, Martin CA, Burgess DR, Burgess DS.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.
    Joshi M, Bernstein J, Solomkin J, Wester BA, Kuye O.
    J Antimicrob Chemother; 1999 Mar; 43(3):389-97. PubMed ID: 10223595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.